ArticleeLife2023
Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic.
Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: An Evaluation of the COVID-19 Pandemic.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Behavioral changes and delayed colorectal cancer diagnosis during COVID-19: a real-world survey analysis.BMC gastroenterology · 2025Article
- Should We Screen Sooner? Elevated CRC Incidence in Solid Organ Transplant Recipients in the United States Before and After the COVID-19 Pandemic.JGH open : an open access journal of gastroenterology and hepatology · 2025Article
- Article
- Effect of the COVID-19 pandemic on colorectal cancer screening in two university-affiliated health care systems.PloS one · 2025Article
- DISTRIBUTED MODEL EXPLORATION WITH EMEWS.Proceedings of the ... Winter Simulation Conference. Winter Simulation Conference · 2024Article
- Resilience Gap in Gastrointestinal Endoscopy Activity during the COVID-19 Pandemic in South Korea.Chonnam medical journal · 2024Article
- Article
- Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis.Cancer medicine · 2024Article
- Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.JAMA health forum · 2024Article
- Colorectal Screening During the COVID-19 Pandemic: Delayed but Not Forgotten.Digestive diseases and sciences · 2023Article
- The Impact of COVID-19 Pandemic on Nationwide Colorectal Cancer Screening Rates in Israel, an Observational Study.Cancer control : journal of the Moffitt Cancer CenterObservational
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
The aftermath of the initial phase of the COVID-19 pandemic may contribute to the widening of disparities in colorectal cancer (CRC) outcomes due to differential disruptions to CRC screening. This comparative microsimulation analysis uses two CISNET CRC models to simulate the impact of ongoing screening disruptions induced by the COVID-19 pandemic on long-term CRC outcomes. We evaluate three channels through which screening was disrupted: delays in screening, regimen switching, and screening discontinuation. The impact of these disruptions on long-term CRC outcomes was measured by the number of life-years lost due to CRC screening disruptions compared to a scenario without any disruptions. While short-term delays in screening of 3-18 months are predicted to result in minor life-years loss, discontinuing screening could result in much more significant reductions in the expected benefits of screening. These results demonstrate that unequal recovery of screening following the pandemic can widen disparities in CRC outcomes and emphasize the importance of ensuring equitable recovery to screening following the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.